Literature DB >> 23565338

OSTEOPONTIN: A KEY LINK BETWEEN IMMUNITY, INFLAMMATION AND THE CENTRAL NERVOUS SYSTEM.

Amanda Brown1.   

Abstract

Osteopontin (OPN) is a pro-inflammatory cytokine that can be secreted from many cells including activated macrophages and T-lymphocytes. Elevated levels of osteopontin in the plasma, cerebrospinal fluid or brain of individuals with neurodegenerative diseases such as multiple sclerosis (MS), Parkinson's and Alzheimer's disease and more recently in HIV-associated neurocognitive disorder has been reported. However, except for the case of MS, little is known regarding the molecular mechanisms by which OPN may exacerbate disease. Alternatively, OPN through its ability to promote cell survival may in some contexts function in the brain in a protective capacity. OPN has several protein motifs that allow it to engage with several different signaling pathways involved in immunity and inflammation. A better understanding of the cellular pathways that are regulated by OPN in cells of the central nervous system is required to uncover its putative role in neuronal homeostasis.

Entities:  

Keywords:  CD44; HIV-associated neurocognitive disorder; Integrin; Macrophage; Microglia; Neurodegeneration

Year:  2012        PMID: 23565338      PMCID: PMC3616337          DOI: 10.2478/s13380-012-0028-7

Source DB:  PubMed          Journal:  Transl Neurosci        ISSN: 2081-6936            Impact factor:   1.757


  67 in total

1.  Novel cerebrospinal fluid biomarkers of axonal degeneration in frontotemporal dementia.

Authors:  Niklas Mattsson; Ulla Rüetschi; Yolande A L Pijnenburg; Marinus A Blankenstein; Vladimir N Podust; Susann Li; Inger Fagerberg; Lars Rosengren; Kaj Blennow; Henrik Zetterberg
Journal:  Mol Med Rep       Date:  2008 Sep-Oct       Impact factor: 2.952

Review 2.  HIV and bone metabolism.

Authors:  Ighovwerha Ofotokun; M Neale Weitzmann
Journal:  Discov Med       Date:  2011-05       Impact factor: 2.970

3.  HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.

Authors:  Amanda Brown; Suzanne Gartner; Thomas Kawano; Nicole Benoit; Cecilia Cheng-Mayer
Journal:  J Leukoc Biol       Date:  2005-07-06       Impact factor: 4.962

4.  Osteopontin enhances HIV replication and is increased in the brain and cerebrospinal fluid of HIV-infected individuals.

Authors:  Amanda Brown; Tanzeem Islam; Robert Adams; Sujata Nerle; Masiray Kamara; Caitlin Eger; Karen Marder; Bruce Cohen; Giovanni Schifitto; Justin C McArthur; Ned Sacktor; Carlos A Pardo
Journal:  J Neurovirol       Date:  2011-05-10       Impact factor: 2.643

5.  Osteopontin is increased in the cerebrospinal fluid of patients with Alzheimer's disease and its levels correlate with cognitive decline.

Authors:  Cristoforo Comi; Miryam Carecchio; Annalisa Chiocchetti; Stefania Nicola; Daniela Galimberti; Chiara Fenoglio; Giuseppe Cappellano; Francesco Monaco; Elio Scarpini; Umberto Dianzani
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

6.  Bone turnover, osteoprotegerin/RANKL and inflammation with antiretroviral initiation: tenofovir versus non-tenofovir regimens.

Authors:  Todd T Brown; Allison C Ross; Norma Storer; Danielle Labbato; Grace A McComsey
Journal:  Antivir Ther       Date:  2011

7.  Osteopontin levels and increased disease activity in relapsing-remitting multiple sclerosis patients.

Authors:  M H J Vogt; S Floris; J Killestein; D L Knol; M Smits; F Barkhof; C H Polman; L Nagelkerken
Journal:  J Neuroimmunol       Date:  2004-10       Impact factor: 3.478

Review 8.  Control of osteopontin signaling and function by post-translational phosphorylation and protein folding.

Authors:  Christian C Kazanecki; Dana J Uzwiak; David T Denhardt
Journal:  J Cell Biochem       Date:  2007-11-01       Impact factor: 4.429

9.  Validation of the CNS Penetration-Effectiveness rank for quantifying antiretroviral penetration into the central nervous system.

Authors:  Scott Letendre; Jennifer Marquie-Beck; Edmund Capparelli; Brookie Best; David Clifford; Ann C Collier; Benjamin B Gelman; Justin C McArthur; J Allen McCutchan; Susan Morgello; David Simpson; Igor Grant; Ronald J Ellis
Journal:  Arch Neurol       Date:  2008-01

Review 10.  Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene.

Authors:  R Patarca; R A Saavedra; H Cantor
Journal:  Crit Rev Immunol       Date:  1993       Impact factor: 2.214

View more
  27 in total

1.  Anti-inflammatory effects of thymoquinone in activated BV-2 microglial cells.

Authors:  Equar Taka; Elizabeth A Mazzio; Carl B Goodman; Natalie Redmon; Hernan Flores-Rozas; Renee Reams; Selina Darling-Reed; Karam F A Soliman
Journal:  J Neuroimmunol       Date:  2015-06-27       Impact factor: 3.478

2.  Osteopontin and clusterin levels in type 2 diabetes mellitus: differential association with peripheral autonomic nerve function.

Authors:  Raelene E Maser; M James Lenhard; Ryan T Pohlig; P Babu Balagopal
Journal:  Neurol Sci       Date:  2017-06-21       Impact factor: 3.307

Review 3.  Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: Current Evidence and Future Perspectives.

Authors:  Donovan A McGrowder; Fabian Miller; Kurt Vaz; Chukwuemeka Nwokocha; Cameil Wilson-Clarke; Melisa Anderson-Cross; Jabari Brown; Lennox Anderson-Jackson; Lowen Williams; Lyndon Latore; Rory Thompson; Ruby Alexander-Lindo
Journal:  Brain Sci       Date:  2021-02-10

Review 4.  Monocytes mediate HIV neuropathogenesis: mechanisms that contribute to HIV associated neurocognitive disorders.

Authors:  Dionna W Williams; Mike Veenstra; Peter J Gaskill; Susan Morgello; Tina M Calderon; Joan W Berman
Journal:  Curr HIV Res       Date:  2014       Impact factor: 1.581

5.  Noncontiguous Protein Interaction Domains in Osteopontin Contribute to Enhance HIV-1 Replication.

Authors:  Caitlin Eger; Kimberly Cirelli; Jessica Budiaman; Amanda Brown
Journal:  J Hum Virol Retrovirol       Date:  2014-05-23

6.  Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function.

Authors:  Raelene E Maser; M James Lenhard; Ryan T Pohlig; P Babu Balagopal
Journal:  J Diabetes Complications       Date:  2015-12-17       Impact factor: 2.852

7.  Osteopontin in cerebrospinal fluid as diagnostic biomarker for central nervous system lymphoma.

Authors:  Felicitas Strehlow; Sandra Bauer; Peter Martus; Michael Weller; Patrick Roth; Uwe Schlegel; Sabine Seidel; Carmen Scheibenbogen; Agnieszka Korfel; Stephan Kreher
Journal:  J Neurooncol       Date:  2016-06-13       Impact factor: 4.130

8.  Association Between Osteopontin Gene Polymorphisms and Cerebral Palsy in a Chinese Population.

Authors:  Qing Shang; Chongchen Zhou; Dongzhi Liu; Wenxia Li; Mingjie Chen; Yiran Xu; Fei Wang; Dan Bi; Xiaoli Zhang; Xinzhi Zhao; Lei Wang; Changlian Zhu; Qinghe Xing
Journal:  Neuromolecular Med       Date:  2016-04-25       Impact factor: 3.843

9.  CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.

Authors:  Kenneth L McClain; Jennifer Picarsic; Rikhia Chakraborty; Daniel Zinn; Howard Lin; Harshal Abhyankar; Brooks Scull; Albert Shih; Karen Phaik Har Lim; Olive Eckstein; Joseph Lubega; Tricia L Peters; Walter Olea; Thomas Burke; Nabil Ahmed; M John Hicks; Brandon Tran; Jeremy Jones; Robert Dauser; Michael Jeng; Robert Baiocchi; Deborah Schiff; Stanton Goldman; Kenneth M Heym; Harry Wilson; Benjamin Carcamo; Ashish Kumar; Carlos Rodriguez-Galindo; Nicholas S Whipple; Patrick Campbell; Geoffrey Murdoch; Julia Kofler; Simon Heales; Marian Malone; Randy Woltjer; Joseph F Quinn; Paul Orchard; Michael C Kruer; Ronald Jaffe; Markus G Manz; Sergio A Lira; D Williams Parsons; Miriam Merad; Tsz-Kwong Man; Carl E Allen
Journal:  Cancer       Date:  2018-04-06       Impact factor: 6.860

10.  A novel role for osteopontin in macrophage-mediated amyloid-β clearance in Alzheimer's models.

Authors:  Altan Rentsendorj; Julia Sheyn; Dieu-Trang Fuchs; David Daley; Brenda C Salumbides; Hannah E Schubloom; Nadav J Hart; Songlin Li; Eric Y Hayden; David B Teplow; Keith L Black; Yosef Koronyo; Maya Koronyo-Hamaoui
Journal:  Brain Behav Immun       Date:  2017-08-30       Impact factor: 19.227

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.